A B S T R A C T When gram-negative bacterial lipopolysaccharides (LPS) are injected intravenously into the rabbit or rat, they bind to plasma lipoproteins, particularly high density lipoproteins (HDL). The present studies were performed to examine the mechanisms by which LPS-HDL complexes are removed from the circulation and taken up by various tissues. Our approach was to compare the sites of specific tissue binding and uptake of HDL and of LPS-HDL complexes in the rat and squirrel monkey. In the rat, binding of homologous 125I-HDL was demonstrated principally in the adrenal gland, ovary, liver, and spleen.
[3H]LPS-HDL complexes (produced in vitro by incubating Salmonella typhimurium [3H] LPS with rat HDL and lipoprotein-free plasma) bound to the same tissues, but with apparently lower affinities. The specificity of binding of both 125I-HDL and [3H]LPS-HDL to these organs was demonstrated in two ways. First, tissue binding of both radiolabeled preparations was swamped out by raising the circulating levels of HDL-cholesterol from 32 to 140 mg/dl. Second, treatment of the animals with dexamethasone abolished specific binding of both HDL preparations to the adrenal gland while administration of adrenocorticotropin increased the specific adrenal binding of the two preparations. The steady-state plasma clearance rate for 1251-HDL equaled 774+29
,ul/h and was significantly lower (557+39 ,l/h) for the LPS-HDL complex, a finding that presumably reflected the lesser ability of the various tissues to bind the LPS-HDL complex. Binding studies were also done in the squirrel monkey, an animal that has the same level of
INTRODUCTION
Although much is known about the toxic activities of gram-negative bacterial lipopolysaccharides (LPS; endotoxins),' an understanding of the mechanisms by which the animal host transports, modifies, and degrades these important molecules is only beginning to emerge. Recent evidence suggests that, after an intravenous injection of LPS into the rabbit or rat, a significant fraction of the LPS binds to plasma lipoproteins, particularly to high density lipoproteins (HDL) (1, 2) . LPS that have bound to HDL undergo a decrease in density (to p < 1.21 g/ml) and have a longer half-life in the plasma space; indeed, most of the LPS that remain in the plasma after intravenous bolus injection appear to be bound to HDL (3) . LPS that do not bind to HDL in plasma are apparently rapidly trapped in tissues such as the spleen, liver, and lung (3) .
In studies done in rabbits, Mathison and Ulevitch (3) found that LPS that are bound to HDL ("low- ' Abbreviations used in this paper: BSA, bovine serum albumin; HDL, high density lipoproteins; LPS, lipopolysaccharides.
density" LPS) are taken up preferentially by the adrenal gland. There are several mechanisms that might account for the uptake of LPS-HDL complexes by different tissues. First, LPS might follow HDL to those tissues that ordinarily take up HDL. Second, LPS might change the properties of HDL so that the normal binding of HDL to tissue receptors is altered. Third, tissue uptake of LPS-HDL complexes might be dependent primarily upon LPS uptake; by rendering the LPS more bulky or by altering their net charge, bound HDL might protect LPS from phagocytosis or other mechanisms that account for the trapping of LPS in the liver and spleen.
To examine these various possibilities, we have compared the sites of tissue binding and uptake of HDL and LPS-HDL complexes. Most of the experiments were performed in the rat, an animal in which the majority ofthe plasma cholesterol is carried in HDL. To a limited degree, similar comparisons were also carried out in the squirrel monkey, an animal in which low density lipoproteins (LDL) are quantitatively a more important carrier of plasma cholesterol. Our results indicate that LPS-HDL complexes are taken up by the same tissues that take up HDL, though the LPS-HDL complexes are bound to these tissues with slightly less affinity than HDL. Moreover, hormonal changes which modify the uptake of HDL by certain tissues also influence the uptake of LPS-HDL complexes. The ultimate disposition of "circulating" endotoxin thus may depend critically upon the factors that influence the binding of LPS to HDL and the uptake ofHDL by target tissues.
METHODS
Animal preparations. Female, Sprague-Dawley derived rats weighing 125-150 g were purchased from Charles River Breeding Laboratories, Inc., Wilmington, Mass. They were housed and fed as previously described (4) for at least 2 wk before being used in specific experiments. By that time they weighed 190-220 g. The squirrel monkeys (Saimiri sciureus) were shipped to the laboratory from South American Primates, Inc., Miami, Fla. and were placed in isolation for 6-8 wk before use. During this time they were allowed free access to water and monkey chow (Wayne Monkey Diet, Allied Mills, Inc., Chicago, Ill.) and were given orange juice once each week. They were screened for tuberculosis and parasites. By the time they were used for experiments, the monkeys had achieved stable weights in the range of 680 to 790 g.
Lipoprotein and albumin preparations. HDL from both rat and monkey plasma were prepared in a narrow density range to avoid contamination with lower density lipoproteins. Using fed animals maintained on a low cholesterol chow diet, blood was aspirated from the abdominal aorta (rats) or from the femoral vein (monkeys) and anticoagulated with EDTA (1 mg/ml). HDL were then harvested from the plasma between the densities of 1.095 and 1.21 g/ml. The lipoproteins were washed and concentrated by centrifuging an additional time at p = 1.21 g/ml. These HDL preparations ran as a single band with alpha mobility on agarose gel electrophoresis (5) . On 12.5% polyacrylamide-SDS gels (6) the rat HDL showed a major apoprotein band corresponding to apo AI and a consistent, but more minor band, corresponding to apo E as has been reported (7, 8) . The constituents of plasma that sedimented at a density of 1.21 g/ml ("1.21 bottom") were dialyzed against 0.9% NaCl and kept at 4°C prior to use.
The rat and monkey lipoproteins were then either labeled with 1251 or bound to bacterial [3H]LPS. HDL and bovine serum albumin (BSA) were radioiodinated by a modification of the method of McFarlane and others (9, 10) (12) . LPS were extracted from cell envelopes (12) by the phenol-water method of Westphal and Jann (13) and treated with diethyl ether, RNAase, DNAase, and pronase to remove contaminants (14) . LPS were then sedimented by ultracentrifugation in distilled water (100,000 g, 4 h, 4°C) and lyophilized. For each experiment, small amounts of LPS were suspended in saline and treated for 30-60 s in a water bath sonicator to achieve a uniform suspension. The preparations used in these experiments contained -10,000-16,000 cpm/,ug of LPS.
In vitro binding ofLPS and HDL. Greater than 98% of the purified LPS used in these experiments sedimented to the bottom of tubes at a density of 1.21 solution containing NaCl (0.9 g/dl), glucose (0.2 g/dl), and BSA (0.1 g/dl) at a rate of 1.2 ml/h. Trace quantities of [3H]-LPS-HDL or 1251-HDL were added to the infusates of different groups of animals to give -50,000-100,000 cpm/ml of radioactivity. The infusions were then continued at a constant rate for 14 h. At that time the animals were anesthetized and blood was aspirated from the abdominal aorta as quickly as possible. The delivery rate of each pump was calibrated by allowing it to continue to deliver the infusate directly into counting vials for two consecutive 30-min periods. These samples, along with triplicate 100-.ul aliquots ofplasma, were then assayed for radioactivity. Aliquots of the infusate and plasma also were subjected to lipid extraction and to precipitation with trichloroacetic acid. The clearance rate from the plasma of each labeled compound was then calculated as follows: Clearance rate = (protein-bound counts per minute infused into the animal per hour)/(protein-bound counts per minute per microliter of plasma). The values are expressed as the microliters of plasma cleared of a particular lipoprotein or LPS preparation per hour (microliters per hour), normalized to 100 g of body wt.
Chemical methods. Plasma cholesterol levels were determined colorimetrically (16) . Protein was measured by the method of Lowry et al. (17) .
Analysis of data. In all cases the data are presented as mean values± 1 SEM. Where appropriate, the difference between the mean values for two groups of data were tested by the unpaired Student's t test. In the various figures, those values that are significantly different from 0 at the P < 0.05 level are indicated by an asterisk.
RESULTS
Stability ofLPS-HDL complexes. Two types of preliminary experiments were carried out. First, [3H]LPS-HDL complexes were prepared, suspended in KBr p = 1.21 g/ml), and centrifuged at 225,000 g for 36 h at 4°C: 98% of the 3H was found in the top 1 cm of the tube. The complexes were resuspended and recentrifuged two additional times; again, 97.5 and 99% of the radioactivity floated to the tops of the tubes. Because unbound LPS have a density > 1.21 gIml, this experiment indicated that the complexes were stable under these rather extreme conditions of centrifugation.
In the second preliminary experiment the [3H]LPS-HDL complexes were injected intravenously into 20 rats and groups of these animals were killed at intervals from 0.5 to 14 h later. Aliquots of plasma from each rat were adjusted to the densities of 1.095 and 1.21 g/ml and centrifuged. At every time point tested, from 96 to 99% of the 3H floated in the density range of 1.095-1.21 g/ml. We concluded from this experiment that there was no demonstrable transfer of the [3H] LPS from HDL to other lipoprotein fractions of lower density under these in vivo conditions.
1251-HDL and [3H]LPS-HDL binding in the rat.
The rats used in these studies had been maintained on a low cholesterol intake; the total plasma cholesterol averaged 64 +4 mg/dl and, as reported (18) , the majority of this was carried in HDL. As seen in Fig. 1 , -58% of the plasma cholesterol floated in the p = 1.095-1.21 g/ml density range (HDL) and only 14% floated in the p = 1.020-1.055 g/ml fraction (mostly LDL); 21% was in the p = 1.055-1.095 g/ml fraction (LDL and HDL), and lesser amounts were recovered in the other density classes. When such animals were administered [3H]LPS-HDL intravenously and killed at various time intervals, there were markedly different amounts of 3H found in the various tissues (Fig. 2) . From the amount of [3H]LPS-HDL injected and the concentration of 3H in the plasma 5 min after the injections, it was calculated that the LPS-HDL complex had been distributed into a volume equal to 4.25±0.12 ml/100 g body wt: this volume of distribution essentially equals the plasma volume in the rat [4.04 ml/100 g (19)]. The plasma concentration of [3H]LPS-HDL then declined over the subsequent 2 h as an apparent first-order decay curve. As is also shown in Fig. 2 , very high concentrations of 3H were achieved in the adrenal gland, ovary, and liver only 5 min after the injection, after which there was a progressive, but much slower, 6 . Individual rats were administered intravenously from 0 to 15 mg of HDL-cholesterol, after which the tissue spaces (Panels A and C) and specific tissue spaces (Panels B and D) were measured at 10 min for both 125I-HDL and [3H]LPS-HDL. As the plasma HDL-cholesterol concentration was raised, the tissue spaces for both compounds decreased significantly in the adrenal gland, ovary, and liver and the specific binding (Panels B and D) dropped essentially to zero. In a second group of studies, the effect of manipulating the circulating levels of ACTH on tissue binding of HDL was explored. As summarized by the data in Fig. 7 , groups of rats were administered either a buffer solution (control), dexamethasone, or ACTH, and tissue spaces for 125I-BSA, 1251-HDL, and [3H] LPS-HDL were measured at 10 min in all three groups. As seen in panels A and D, specific tissue binding was again seen in the adrenal gland, ovary, and liver for both 1251 [3H]LPS binding to HDL in vivo in the rat. The previous studies indicated that the bacterial LPS, once attached to HDL, was bound to and presumably taken up by the same group of tissues that normally bind and take up HDL. The next group of studies was designed to determine how rapidly purified LPS bind to HDL and other plasma lipoproteins under in vivo conditions and to determine the sites of tissue uptake of LPS at 10 min. Purified [3H]LPS were administered intravenously as a bolus to rats at time 0 and animals were killed at intervals up to 2 h later. The initial plasma concentration of [3H]LPS, estimated by assuming a plasma volume of 4.04 ml/100 g body wt (19), averaged 6.2 ,ug/ml. The measured plasma concentration of [3H]LPS fell over the first 10 min after injection to a level of 3.5 ,ug/ml and then decreased gradually to 2.9 ,ug/ml at 120 min. Binding of the [3H]LPS to plasma lipoproteins was determined by measuring the percentage of the [3H]LPS in plasma that floated at p = 1.21 g/ml. As shown in Fig. 8, <2% of the plasma LPS floated at this density when added to rat plasma at 0°C (time 0 point). However, 0.5 min after administration of the [3H]LPS to the animals, 37% had acquired animals averaged 88 ±4 mg/dl and, as seen in Fig. 1 (Figs. 3 and 4) . Furthermore, this putative binding could be swamped out if the circulating levels of HDL were acutely elevated (Panel C ofFig. 5 and Fig. 6 ) and, in the case of the adrenal gland, could be increased or totally abolished by altering the degree of stimulation of the adrenal cells by ACTH (Fig. 7) . Taken together, these three sets of observations strongly suggest that the specific HDL tissue spaces measured in these studies and shown in Fig. 5 (24, 25) . Such findings imply that many tissues of the rat normally obtain much of the cholesterol they require through the uptake of lipoprotein-cholesterol from the plasma and so respond to changes in circulating levels of these lipoproteins by reciprocal changes in the rates of tissue sterol synthesis.
In the rat, most of the plasma cholesterol is carried in HDL fractions and most of these appear to contain at least some E apoprotein in addition to the A apoproteins (7, 18) . Hence, it is likely that in this species much of the cholesterol taken up by the various organs is acquired by the tissue uptake of HDL, and that this uptake presumably is mediated through the LDL receptor mechanism or, possibly, in tissues like the endocrine glands, through another transport system (23) (24) (25) .
The second major point to be derived from these experiments concerns the sites of tissue binding and uptake of [3H]LPS-HDL complexes. When the complexes were performed in vitro and then injected intravenously into the animals, they were specifically bound to the same tissues that bound 125I-HDL. This was true in the squirrel monkey (Fig. 11) as well as in the rat (Fig. 5) . Furthermore, the specific [3H]LPS-HDL binding was also eliminated by raising the circulating levels of HDL (Figs. 5,6 ) and, in the adrenal gland, was altered by the administration of either dexamethasone or ACTH (Fig. 7) We thus measured the accumulation of 3H in the tissues of the rat for several hours after the bolus injection of [3H]LPS-HDL. After the initial rapid binding phase there was a progressive, apparently linear, accumulation of label in tissues such as the adrenal gland, ovary, and liver (Fig. 2) . Furthermore, the same tissues that showed specific 125I-HDL binding in 10 min (Fig. 5 ) also demonstrated the greatest amounts of tissue accumulation of 3H 14 h after administration of [3H]LPS-HDL (Fig. 10) . Thus, regardless of the isotope used or the time period allowed for accumulation of label, the highest rates of HDL binding/uptake were found in the adrenal gland, ovary, liver, gastrointestinal tract, and spleen. When these values (expressed per gram of tissue) are multiplied by the organ weights, the liver becomes the single most important site of uptake and, for example, accounts for about 56% of the 3H that was recovered from the tissues of the rat 14 h after the administration of [3H]LPS-HDL. These results are in general agreement with those obtained using 125I1 LPS in the rabbit (3).
The third set of studies concerned the magnitude of the binding that takes place in vivo between LPS and HDL and the sites of tissue uptake of the LPS. When [3H]LPS were administered intravenously, only 30% were associated with lipoproteins at 10 min and even at 2 h only 70% ofthe LPS in plasma were lipoprotein-bound. At 10 min, the amount of specific binding of [3H]LPS to the adrenal gland and ovary was only about half (Fig. 9) of that observed when preformed [3H]LPS-HDL were administered (Fig. 5) . This reduction in specific binding by the endocrine glands reflected very closely the observation that only about half of the [3H]LPS in the plasma at this time point was associated with HDL. Thus it appears that if the association of the [3H]LPS with HDL could have been totally blocked, the LPS would have been cleared entirely by the liver, spleen, and lung: three tissues that are rich in phagocytic cells. On the other hand, once the LPS becomes associated with HDL, uptake by the phagocytic cells decreases and binding to the parenchymal cells of the adrenal gland, ovary, liver, etc., is promoted through receptor-mediated lipoprotein binding. These conclusions are entirely consistent with results recently reported by Mathison and Ulevitch (3) in the rabbit. These authors found that intravenously administered 125I-LPS disappeared from the plasma as a two-component process. There was an initial rapid phase of disappearance that was associated with the accumulation of large amounts of radioactivity in the phagocytes of the liver, spleen, and lung (presumably, this rapid uptake represented the clearance of LPS not bound to lipoproteins in vivo). The second, and slower, phase of disappearance was associated with a reduction in the density of LPS in plasma (to <1.2 g/ml); radioactivity accumulated preferentially in the adrenal gland (presumably, the lipoprotein-mediated uptake of LPS-HDL complexes). Thus, once LPS become bound to HDL they are apparently targeted to the adrenal gland in the rat, rabbit, and squirrel monkey.
The biological importance of HDL-mediated uptake of LPS by the adrenal gland is unknown, but it is at least possible that this mechanism may account for the occurrence of adrenal hemorrhage in some patients with gram-negative bacterial sepsis (26) . Evidence supporting this hypothesis was described by Levin and Cluff (27) , who found that the incidence of adrenal hemorrhage in rabbits given bolus doses of LPS could be increased by the prior administration of ACTH and decreased by the administration ofdexamethasone. Our results suggest that these hormonal treatments should increase (ACTH) or decrease (dexamethasone) the uptake of LPS-HDL complexes by the adrenal gland. One may thus speculate that in some individuals with gram-negative bacteremia, LPS that have dissociated from the bacteria bind to HDL. The stress of sepsis is often associated with elevations in ACTH levels, which would augment adrenal gland uptake of the LPS-HDL complexes. Although essentially nothing is known about the cellular uptake of these complexes, it is conceivable that in some patients the accumulation of LPS in this manner may provoke adrenal cortical insufficiency (28, 29) or hemorrhage.
These and previous studies (3) 
